Navigated to Targeted Therapies for NSCLC: Where Are We Today?

Targeted Therapies for NSCLC: Where Are We Today?

September 11
38 mins

Episode Description

Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

Credit available for this activity expires: 9/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu

See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.